Amedeo's Top 20

Amedeo Smart

Independent Medical Education

09 October 2017

Multidisciplinary Journal Club

  1. Johnson SB, Park HS, Gross CP, Yu JB, et al.
    Use of Alternative Medicine for Cancer and Its Impact on Survival.
    J Natl Cancer Inst 2018;110.

  1. Adams TD, Davidson LE, Litwin SE, Kim J, et al.
    Weight and Metabolic Outcomes 12 Years after Gastric Bypass.
    N Engl J Med 2017;377:1143-1155.

  2. Postuma RB, Anang J, Pelletier A, Joseph L, et al.
    Caffeine as symptomatic treatment for Parkinson disease (Cafe-PD): A randomized trial.
    Neurology 2017.

  3. Takata MA, Goncalves-Carneiro D, Zang TM, Soll SJ, et al.
    CG dinucleotide suppression enables antiviral defence targeting non-self RNA.
    Nature 2017.

  4. Le Gouill S, Thieblemont C, Oberic L, Moreau A, et al.
    Rituximab after Autologous Stem-Cell Transplantation in Mantle-Cell Lymphoma.
    N Engl J Med 2017;377:1250-1260.

  1. Mas JL, Derumeaux G, Guillon B, Massardier E, et al.
    Patent Foramen Ovale Closure or Anticoagulation vs. Antiplatelets after Stroke.
    N Engl J Med 2017;377:1011-1021.

  2. Yartel AK, Rein DB, Ann Brown K, Krauskopf K, et al.
    Hepatitis C Virus Testing for Case Identification in Persons Born during 1945-1965: Results from Three Randomized Controlled Trials.
    Hepatology 2017.

  3. Annane D, Pastores SM, Rochwerg B, Arlt W, et al.
    Guidelines for the Diagnosis and Management of Critical Illness-Related Corticosteroid Insufficiency (CIRCI) in Critically Ill Patients (Part I): Society of Critical Care Medicine (SCCM) and European Society of Intensive Care Medicine
    Crit Care Med 2017.

  4. Bandos H, Melnikow J, Rivera DR, Swain SM, et al.
    Long-term Peripheral Neuropathy in Breast Cancer Patients Treated With Adjuvant Chemotherapy: NRG Oncology/NSABP B-30.
    J Natl Cancer Inst 2018;110.

  5. Sondergaard L, Kasner SE, Rhodes JF, Andersen G, et al.
    Patent Foramen Ovale Closure or Antiplatelet Therapy for Cryptogenic Stroke.
    N Engl J Med 2017;377:1033-1042.

  1. Xie YL, Chakravorty S, Armstrong DT, Hall SL, et al.
    Evaluation of a Rapid Molecular Drug-Susceptibility Test for Tuberculosis.
    N Engl J Med 2017;377:1043-1054.

  2. Chen SC, Jeng KS, Lai MMC.
    Zinc finger-containing cellular transcription corepressor ZBTB25 promotes influenza virus RNA transcription and is a target for zinc-ejector drugs.
    J Virol 2017.

  3. Turner JM, Peixoto AJ.
    Blood pressure targets for hemodialysis patients.
    Kidney Int 2017;92:816-823.

  4. Hourigan CS, Gale RP, Gormley NJ, Ossenkoppele GJ, et al.
    Measurable residual disease testing in acute myeloid leukaemia.
    Leukemia 2017;31:1482-1490.

  5. Davids MS.
    Targeting BCL-2 in B-cell lymphomas.
    Blood 2017;130:1081-1088.

  1. Rivera DR, Ganz PA, Weyrich MS, Bandos H, et al.
    Chemotherapy-Associated Peripheral Neuropathy in Patients With Early-Stage Breast Cancer: A Systematic Review.
    J Natl Cancer Inst 2018;110.

  2. Fissolo N, Pignolet B, Matute-Blanch C, Trivino JC, et al.
    MMP9 is decreased in natalizumab-treated MS patients at risk for PML.
    Ann Neurol 2017.

  3. Palpacuer C, Duprez R, Huneau A, Locher C, et al.
    Pharmacologically controlled drinking in the treatment of alcohol dependence or alcohol use disorders: a systematic review with direct and network meta-analyses on nalmefene, naltrexone, acamprosate, baclofen and topiramate.
    Addiction 2017.

  4. Kapur S, Barbhaiya C, Deneke T, Michaud GF, et al.
    Esophageal Injury and Atrioesophageal Fistula Caused by Ablation for Atrial Fibrillation.
    Circulation 2017;136:1247-1255.

  5. Lear SA, Hu W, Rangarajan S, Gasevic D, et al.
    The effect of physical activity on mortality and cardiovascular disease in 130 000 people from 17 high-income, middle-income, and low-income countries: the PURE study.
    Lancet 2017.


Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016